To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development

Inclusion Criteria: * Patients who are above 18 years of age * Patients with Cirrhosis and SBP (community acquired /Health care associated/ nosocomial) with baseline Creatinine \<1mg/dl, Bilirubin \<4mg/dl Exclusion Criteria: * Antibiotic treatment within one week before the diagnosis of SBP (except for prophylactic treatment with norfloxacin) * Significant cardiac failure, pulmonary disease * Known Chronic Kidney Disease or findings suggestive of organic nephropathy (proteinuria, haematuria, or abnormal findings on renal USG) * Hepatocellular carcinoma * HIV infection; * GI bleed within 1 month before the study * Ileus * Grade 3 to 4 hepatic encephalopathy * Other types of infection * Shock * Serum Bilirubin ≥4 mg/dL and Serum Creatinine ≥ 1 mg/dl at presentation * Patients requiring Albumin for any other indication. * Presence of any potential causes of dehydration (such as diarrhea or an intense response to diuretic treatment) within one week before the diagnosis of SBP).